Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Schulz

Showing results (321-330 of 345) with videos related to

Pageof 35
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 21, 2025
Corrigendum to "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" [Eur J Cancer 176 (2022) 88-99]Thomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2022
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of lifeThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Data in Brief|November 25, 2022
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseasesThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2017
Adherence of Heart Transplant Recipients to Prescribed Medication and Recommended Lifestyle HabitsY Brocks, A Zittermann, D Grisse, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of lazaroid effects on severe acute pancreatitis in ratsH U Schulz, H Hoenl, T Schrader, et al.
Bone Marrow Transplantation|February 16, 2000
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantationE Holler, M G Roncarolo, R Hintermeier-Knabe, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
Cellular Immunology|February 13, 2001
High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseasesR Claus, T Bittorf, H Walzel, et al.
International Journal of Cancer|December 22, 1999
Radiotherapy for stages I and IIA/B testicular seminomaM Bamberg, H Schmidberger, C Meisner, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 10, 2001
Outcome of heart transplantation in patients previously infected with hepatitis C virusM Castella, G Tenderich, M M Koerner, et al.
Pageof 35

Showing results (321-330 of 345) with videos related to

Sort By:
Pageof 35
European Journal of Cancer (Oxford, England : 1990)|January 21, 2025
Corrigendum to "Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life" [Eur J Cancer 176 (2022) 88-99]Thomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2022
Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of lifeThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Data in Brief|November 25, 2022
Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseasesThomas U Schulz, Sarah Zierold, Michael M Sachse, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2017
Adherence of Heart Transplant Recipients to Prescribed Medication and Recommended Lifestyle HabitsY Brocks, A Zittermann, D Grisse, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of lazaroid effects on severe acute pancreatitis in ratsH U Schulz, H Hoenl, T Schrader, et al.
Bone Marrow Transplantation|February 16, 2000
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantationE Holler, M G Roncarolo, R Hintermeier-Knabe, et al.
Medical Oncology (Northwood, London, England)|November 4, 2017
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trialI Walter, U Schulz, M Vogelhuber, et al.
Cellular Immunology|February 13, 2001
High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseasesR Claus, T Bittorf, H Walzel, et al.
International Journal of Cancer|December 22, 1999
Radiotherapy for stages I and IIA/B testicular seminomaM Bamberg, H Schmidberger, C Meisner, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 10, 2001
Outcome of heart transplantation in patients previously infected with hepatitis C virusM Castella, G Tenderich, M M Koerner, et al.
Pageof 35